Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
29.37
+0.50 (1.73%)
At close: Nov 13, 2026, 4:00 PM EST
29.90
+0.53 (1.80%)
After-hours: Nov 13, 2026, 5:31 PM EST
Amphastar Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 204.59 | 170.18 | 151.61 | 144.3 | 156.1 | 126.35 |
Short-Term Investments | 26.05 | 112.64 | 70.04 | 112.51 | 19.66 | 10.32 |
Cash & Short-Term Investments | 230.63 | 282.81 | 221.65 | 256.81 | 175.76 | 136.67 |
Cash Growth | -16.50% | 27.60% | -13.69% | 46.11% | 28.60% | 29.40% |
Accounts Receivable | 182.22 | 143.56 | 136.29 | 114.94 | 88.8 | 78.8 |
Other Receivables | 2.53 | 17.17 | 1.75 | 0.53 | 0.17 | 0.13 |
Receivables | 184.75 | 160.73 | 138.04 | 115.47 | 88.98 | 78.93 |
Inventory | 173.92 | 176.89 | 153.74 | 105.83 | 103.58 | 92.81 |
Prepaid Expenses | 10.95 | 13.15 | 18.21 | 9.06 | 7.56 | 7.27 |
Restricted Cash | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
Other Current Assets | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 |
Total Current Assets | 602.69 | 636.02 | 534.07 | 489.6 | 378.32 | 318.12 |
Property, Plant & Equipment | 388.05 | 353.72 | 344.63 | 315.64 | 264.57 | 271.49 |
Long-Term Investments | - | - | 11 | 15.21 | 2.41 | 3.99 |
Goodwill | 3.3 | 3.4 | 3.05 | 3.22 | 3.13 | 3.31 |
Other Intangible Assets | 637.13 | 562.56 | 587.61 | 610.08 | 34.17 | 35.56 |
Long-Term Deferred Tax Assets | 42.46 | 42.46 | 71.12 | 53.25 | 38.53 | 22.4 |
Other Long-Term Assets | 38.1 | 31.14 | 25.99 | 25.91 | 20.86 | 16.67 |
Total Assets | 1,712 | 1,629 | 1,577 | 1,513 | 741.99 | 671.53 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 34.48 | 32.59 | 30.51 | 25.44 | 20.5 | 22.21 |
Accrued Expenses | 113.73 | 96.76 | 103.1 | 54.75 | 46.19 | 44.17 |
Current Portion of Long-Term Debt | 2.51 | 1.47 | 0.23 | 0.44 | 3.05 | 2.2 |
Current Portion of Leases | 8.72 | 8.1 | 6.8 | 3.91 | 3 | 2.98 |
Current Income Taxes Payable | 2.14 | 0.24 | 9.66 | 1.61 | 4.57 | 9.08 |
Other Current Liabilities | 19.86 | 19 | 23.44 | 139.27 | 17.55 | 23.16 |
Total Current Liabilities | 181.43 | 158.16 | 173.76 | 225.41 | 94.86 | 103.81 |
Long-Term Debt | 610.34 | 608.66 | 601.2 | 588.96 | 72.84 | 74.38 |
Long-Term Leases | 70.13 | 37.77 | 42.31 | 30.34 | 23.69 | 25.1 |
Pension & Post-Retirement Benefits | 2.7 | 2.6 | 2.6 | 2.6 | - | - |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.14 | 0.53 |
Other Long-Term Liabilities | 32.57 | 33.31 | 25.3 | 26.18 | 21.79 | 22.18 |
Total Liabilities | 897.17 | 840.49 | 845.17 | 873.49 | 213.33 | 226.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 562.15 | 535.38 | 505.4 | 486.06 | 455.08 | 422.42 |
Retained Earnings | 741.41 | 666.88 | 568.79 | 409.27 | 271.72 | 180.34 |
Treasury Stock | -482.99 | -408.15 | -332.71 | -247.43 | -189.52 | -150.48 |
Comprehensive Income & Other | -6.02 | -5.31 | -9.18 | -8.48 | -8.62 | -6.77 |
Total Common Equity | 814.55 | 788.81 | 732.3 | 639.42 | 528.66 | 445.52 |
Shareholders' Equity | 814.55 | 788.81 | 732.3 | 639.42 | 528.66 | 445.52 |
Total Liabilities & Equity | 1,712 | 1,629 | 1,577 | 1,513 | 741.99 | 671.53 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 691.69 | 656 | 650.55 | 623.64 | 102.58 | 104.66 |
Net Cash (Debt) | -461.06 | -373.19 | -428.9 | -366.84 | 73.18 | 32.01 |
Net Cash Growth | - | - | - | - | 128.62% | -16.53% |
Net Cash Per Share | -10.18 | -7.74 | -8.24 | -6.92 | 1.40 | 0.64 |
Filing Date Shares Outstanding | 42.65 | 45.37 | 47.65 | 48.1 | 47.9 | 48.15 |
Total Common Shares Outstanding | 42.65 | 45.65 | 47.62 | 48.07 | 48.11 | 47.71 |
Working Capital | 421.25 | 477.86 | 360.31 | 264.19 | 283.46 | 214.31 |
Book Value Per Share | 19.10 | 17.28 | 15.38 | 13.30 | 10.99 | 9.34 |
Tangible Book Value | 174.13 | 222.84 | 141.64 | 26.13 | 491.36 | 406.65 |
Tangible Book Value Per Share | 4.08 | 4.88 | 2.97 | 0.54 | 10.21 | 8.52 |
Land | 7.52 | 7.55 | 7.42 | 7.48 | 7.45 | 7.62 |
Buildings | 196.76 | 196.68 | 169.43 | 168.77 | 130.73 | 130.58 |
Machinery | 354.52 | 342.1 | 313.38 | 291.43 | 237.74 | 235.26 |
Construction In Progress | 36.74 | 24.41 | 36.69 | 18.68 | 50.84 | 41.19 |
Leasehold Improvements | 46.54 | 46.1 | 42.01 | 41.69 | 31.54 | 29.22 |